Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

Lundback, 1998, Epidemiology of rhinitis and asthma, Clin Exp Allergy, 28, 3 Malone, 1997, A cost of illness study of allergic rhinitis in the United States, J Allergy Clin Immunol, 99, 22 Bousquet, 1996, Pathophysiology of allergic rhinitis, Int Arch Allergy Immunol, 110, 207, 10.1159/000237289 Naclerio, 1991, The role of leukotrienes in allergic rhinitis: a review, Am Rev Respir Dis, 143, S91, 10.1164/ajrccm/143.5_Pt_2.S91 Meltzer, 2000, Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of “one linked airway disease”, Ann Allergy Asthma Immunol, 84, 176, 10.1016/S1081-1206(10)62750-0 Knapp, 1994, Leukotrienes as mediators of nasal inflammation, Adv Prostaglandin Thromboxane Leukot Res, 22, 279 Bisgaard, 1986, Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans, Clin Allergy, 16, 289, 10.1111/j.1365-2222.1986.tb01960.x Okuda, 1988, The role of leukotriene D4 in allergic rhinitis, Ann Allergy, 60, 537 Storms, 2001, Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > 6 years, Clin Exp Allergy, 31, 77, 10.1046/j.1365-2222.2001.00969.x Reiss, 1998, Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group, Arch Intern Med, 158, 1213, 10.1001/archinte.158.11.1213 Knorr, 1998, Montelukast for chronic asthma in 6-to 14-year old children. A randomized, double-blind trial, JAMA, 279, 1181, 10.1001/jama.279.15.1181 Knorr, 2000, Montelukast (MK-0476) improves asthma over a 3-month treatment period in 2- to 5-year-olds, Am J Respir Crit Care Med, 161, A194 Simons, 1999, Allergic rhinobronchitis: the asthma-allergic rhinitis link, J Allergy Clin Immunol, 104, 534, 10.1016/S0091-6749(99)70320-9 Meltzer, 2000, Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial, J Allergy Clin Immunol, 105, 916, 10.1067/mai.2000.106040 Juniper, 1991, Development and testing of a new measure of health status for clinical trials in rhinocon-junctivitis, Clin Exp Allergy, 21, 77, 10.1111/j.1365-2222.1991.tb00807.x Juniper, 1997, Measuring health-related quality of life in rhinitis, J Allergy Clin Immunol, 99, S742, 10.1016/S0091-6749(97)90000-2 Malmstrom, 2001, Montelukast in the treatment of spring allergic rhinitis in a large, double-blind, randomized, placebo-controlled study, J Allergy Clin Immunol, 107, S158 Wilson, 2001, Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis, Clin Exp Allergy, 31, 61, 10.1046/j.1365-2222.2001.00964.x Dykewicz, 1998, Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology, Ann Allergy Asthma Immunol, 81, 478, 10.1016/S1081-1206(10)63155-9 Donnelly, 1995, The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis, Am J Respir Crit Care Med, 151, 1734, 10.1164/ajrccm.151.6.7767514 Pullerits, 1999, Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis, Am J Respir Crit Care Med, 159, 1814, 10.1164/ajrccm.159.6.9810016 Bentley, 1992, Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells, J Allergy Clin Immunol, 89, 877, 10.1016/0091-6749(92)90444-7 Pizzichini, 1999, Montelukast reduces airway eosino-philic inflammation in asthma: a randomized, controlled trial, Eur Respir J, 14, 12, 10.1034/j.1399-3003.1999.14a04.x Volovitz, 1999, Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma, J Allergy Clin Immunol, 104, 1162, 10.1016/S0091-6749(99)70008-4 Henderson, 1994, The role of leukotrienes in inflammation, Ann Intern Med, 121, 684, 10.7326/0003-4819-121-9-199411010-00010 Vignola, 2001, Rhinitis and asthma: a continuum of disease?, Clin Exp Allergy, 31, 674, 10.1046/j.1365-2222.2001.01115.x Jarvis, 2000, Montelukast: a review of its therapeutic potential in persistent asthma, Drugs, 59, 891, 10.2165/00003495-200059040-00015 Wilson, 2001, A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma, Clin Exp Allergy, 31, 616, 10.1046/j.1365-2222.2001.01088.x Reicin, 2000, Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma, Arch Intern Med, 160, 2481, 10.1001/archinte.160.16.2481 Wilson, 2000, Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma, Am J Respir Crit Care Med, 162, 1297, 10.1164/ajrccm.162.4.9912046